Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06972862 · ClinicalTrials.gov registry record · NA

Bone and Body Composition Adaptations to Physical Training

A NA study, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
206
Enrollment target

NCT06972862: Completed NA study, sponsored by University of Pittsburgh.

NCT06972862 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 206 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06972862, a NA study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
206 participants
Enrollment target

Study Summary

The goal of this clinical trial is to evaluate how different exercise programs alter bone density, structure, and strength in adults. It will also collect data on hormones, factors released from skeletal muscle, and body composition. The main questions it aims to answer are: * Do exercise programs that are frequent with high-impact loading will cause greater improvements in bone health? * What changes in hormones, factors released from skeletal muscle, and body composition contribute to bone adaptations? Researchers will compare different exercise groups to see if the type of exercise influences bone adaptation compared to a recreationally active control group. Participants are asked to: * complete questionnaires, 5 blood draws across the study (3 at rest, 2 after strenuous exercise), dual energy x-ray absorptiometry (DXA) scans (to assess bone mineral density and body composition), high resolution tibial scans to assess bone structure and geometry, and physical performance testing. * attend up to 7 testing visits. * (for those randomized to the exercise training intervention) participate in exercise training sessions for 6 months.

Interventions

  • OTHER Osteogenic Index Optimized Exercise Training Program

Trial Details

FieldValue
Enrollment Target 206 participants
Start Date 2022-08-29
Est. Completion 2025-04-27
Phase NA
University of Pittsburgh

1,238 total trials

What the finished NCT06972862 record still lists

NCT06972862 is an interventional study that assigns participants to a tested intervention. The registered 206 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 1 intervention - of which Osteogenic Index Optimized Exercise Training Program is the first listed.

NCT06972862 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06972862 about?

NCT06972862 is a clinical study titled "Bone and Body Composition Adaptations to Physical Training". The goal of this clinical trial is to evaluate how different exercise programs alter bone density, structure, and strength in adults. It will also collect data on hormones, factors released from skeletal muscle, and body composition. The main questions it aims to answer are: * Do exercise programs...

What is the current status of trial NCT06972862?

This trial is currently completed. It is a NA study. The enrollment target is 206 participants. The study started on 2022-08-29. Estimated completion is 2025-04-27.

What interventions are being tested in trial NCT06972862?

The interventions under investigation include: Osteogenic Index Optimized Exercise Training Program (OTHER).

Who is sponsoring clinical trial NCT06972862?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06972862's enrollment target sits among peer trials

206 499th of 2000 higher than 1,502 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03373968 · 206 participants · Phase 2

    Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study

  • NCT03550391 · 206 participants · Phase 3

    Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

  • NCT04757116 · 206 participants · NA

    Post-Market Study to Assess iTind Safety in Comparison to UroLift

  • NCT05675865 · 206 participants · NA

    Cryoablation for Monomorphic Ventricular Tachycardia

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06972862, the US trial registry maintained by the National Library of Medicine. NCT06972862 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.